Rwanda has launched the first mpox vaccination campaign in Africa, marking a significant step in the continent’s fight against the disease. As of Tuesday, the country administered 300 doses of the vaccine to high-risk individuals in a border region with the Democratic Republic of Congo (DRC).

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from Nigeria. Dr.

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in Rwanda, the African Union's disease control centre said Thursday.The first 300 doses were administered on Tuesday near the border with the Democratic Republic of Congo,

The mpox outbreak in Africa is still not under control, the Africa Centres for Disease Control and Prevention (Africa CDC) warned on Thursday, adding that cases were still increasing in several countries.

Mpox is not under control in Africa, the Africa Centres for Disease Control and Prevention (CDC) said on Thursday. Within a week, almost 3,000 new suspected cases of the disease were reported in Africa,

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering the case for using the shot in the 12 to 17 age group to contain an outbreak in parts of Africa.

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17. "Although the overall risk of being infected with mpox for the general EU population remains low,

The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 years old. Approval was based on data from a clinical study of more than 300 adolescents and 200 adults that found non-inferior immune responses and similar safety profile between both age groups after two standard doses